ITW Dr. Fred Jordan, CEO of FinalSpark!

Swiss Startup Revolutionizing AI with Human Neurons. 🧠into🤖

The Future of Computing is Here and Alive: Join the FinalSpark Revolution

FinalSpark, a Swiss startup, is pioneering biocomputing by leveraging living neurons to develop advanced computational systems. Led by visionary Dr. Fred Jordan, FinalSpark cultivates human-derived neuro-organoids that mimic the brain and connects them to in silico systems.

Biocomputers could be a million times more energy-efficient than traditional AI, reducing environmental impact.

FinalSpark's groundbreaking platform is already used by 9 universities globally for cutting-edge biocomputing research. However, scaling up requires overcoming challenges like growing and maintaining large neuron networks.

The team behind FinalSpark is as impressive as its vision. Dr. Fred Jordan and Dr. Martin Kutter are joined by a diverse group of experts, including biologists, engineers, and advisors with decades of experience. This multidisciplinary approach ensures that FinalSpark is not just a tech company but a hub of innovation where different fields converge to create something extraordinary.

This is an opportunity to be part of a revolution:

Deep tech investors: FinalSpark is ready to accelerate R&D in this potentially world-changing technology.

Neurobiologists: Contribute to pioneering research bridging biology and tech by collaborating on FinalSpark's work with hippocampal organoids and memory.

Technologists: With open access and Python programmability, FinalSpark's platform offers a playground for innovation in algorithms, models, and more.

The FinalSpark adventure demands vision, collaboration and pushing boundaries. Are you ready to join and create a future where machines think and learn?

----

Co-host: Dr. Benjamin DELSOL, Quantum Physicist, European Patent Attorney, Expert Deep Tech Innovation / DELSOL

Hosted on Acast. See acast.com/privacy for more information.

Découvrez l'Art de la Communication Efficace avec Audrey Degail, experte en Process Communication Model (PCM). Fondatrice de LINE, elle accompagne les entreprises et leurs équipes pour optimiser leur communication. Dans cet épisode d'E², Audrey partage son parcours inspirant, marqué par une expérience dans le secteur public et une quête de sens et de liberté.

Elle découvre alors le PCM, un outil puissant développé par le Dr. Taibi Kahler, initialement utilisé par la NASA. Il permet de comprendre et d'améliorer les interactions humaines en identifiant les types de personnalités et leurs modes de communication. Pour Audrey, c'est un effet 'waouh', une révélation sur elle-même et les autres.

Elle souligne l'importance de la communication interpersonnelle, différente selon les cultures. En France, elle est souvent vue comme unidirectionnelle, alors qu'aux États-Unis, elle est perçue comme un échange interactif. Audrey insiste sur le fait que la communication efficace nécessite que les deux parties soient sur le même canal.

Le PCM est utilisé par Audrey pour aider les entreprises à améliorer leur communication interne, que ce soit pour résoudre des conflits ou faciliter les transitions. C'est aussi un outil de développement personnel, permettant de mieux se comprendre et comprendre les autres.

Rencontrer Audrey et découvrir le PCM est une expérience enrichissante. Son parcours et sa passion pour la communication sont contagieux. Si vous êtes intéressé par l'amélioration de vos compétences en communication, nous vous encourageons à explorer le PCM. Pour en savoir plus sur Audrey et le PCM, suivez ses interventions.

Audrey Degail | LinkedIn

LINE I workshops I associés I degail I bordeaux (just-line.fr)

Livres recommandés par Audrey

PCM en interaction : Se connecter à soi-même et aux autres (Accompagnement et Coaching)

https://amzn.eu/d/bCFBmO6

L'Intelligence intime

https://amzn.eu/d/8P8GX1A

Le podcast de Maud Ankaoua recommandé par Audrey

https://www.maud-ankaoua.com/podcast.php

Hosted on Acast. See acast.com/privacy for more information.

Unveiling the Secrets of Aging: An Exclusive Interview with Dr. Michael Fossel

This article presents a captivating conversation with Dr. Michael Fossel, a leading expert in aging biology. Co-hosted by Gabriel Cian, the discussion delved into telomere biology, aging research, and medical science's future.

Dr. Fossel's Career: Aging and Telomeres

With a PhD in neurobiology and a Medical Doctorate, Dr. Fossel has dedicated his career to understanding and potentially reversing aging. His work on cellular senescence and telomere shortening has been pivotal. As Telocyte's founder, he's spearheading telomere therapy clinical trials to combat age-related diseases.

From Early Life to Scientific Pursuits

Despite his parents' intelligence backgrounds, Dr. Fossel's fascination with science emerged in high school, initially through mathematics and physics, then psychology and neurobiology. A significant moment at Stanford led him to medical school, where he questioned prevailing views on aging.

Understanding Aging: The Elephant in the Room

Dr. Fossel likens our fragmented understanding of aging to the "blind man and the elephant." He emphasizes that we often fail to see the bigger picture, which led him to clinical medicine, finding emotional satisfaction in improving patients' lives and intellectually understanding age-related diseases.

Telomeres and Telomerase: The Breakthrough

The 1990s were a turning point for Dr. Fossel, with the discovery of telomeres and telomerase providing a cohesive framework to understand aging. This led to his book, "Reversing Human Aging," laying the foundation for future research and potential therapies.

Aging: A Practical Approach

Dr. Fossel's pragmatic approach to aging is inspiring. He argues that the real question is not whether aging is a disease, but what we can do about it. His focus is on alleviating the pain, discomfort, and fear associated with age-related diseases.

Future of Aging Research

Dr. Fossel emphasizes the importance of understanding aging's underlying mechanisms to develop effective interventions. His work with Telocyte aims to translate this knowledge into practical therapies, improving millions' quality of life.

In conclusion, this interview with Dr. Fossel was a profound exploration of aging science, filled with personal anecdotes, scientific insights, and a clear vision for the future. It underscores the importance of interdisciplinary research and a holistic understanding of aging

Michael Fossel | LinkedIn

Telocyte | A future beyond Alzheimer's

Amazon.com: Michael Fossel: books, biography, latest update

---

Gabriel Cian | LinkedIn

What if you could add 10 more years in good health ? (ikare.ai)

2060.life – The Shortest Path to Indefinite Lifespan

Ari Massoudi | LinkedIn

Hosted on Acast. See acast.com/privacy for more information.

Too many STEM researchers publish their work without involving their Technology Transfer Office (TTO).

This implies that you may be losing numerous opportunities to patent and commercialize your work, which could negatively affect both the influence of your research and your prospective financial gains.

What's the Hold Up?

- Is it the time commitment of patenting process?

- The perception of a higher reward from a published article?

- Uncertainty about royalties?

Let's hear from you!

Early engagement with your TTO unlocks valuable insights into your research's commercial potential.

Your Voice Matters!

I am writing a book that compiles the best practices of TTOs for the early detection of patentable elements in scientific discoveries. This book will be published as a free eBook to facilitate the diffusion of deep technology-based innovation.

If you work in a TTO and frequently face the challenge of persuading researchers to collaborate with you, or if you have successfully found a way to make researchers your strongest supporters, your insights would be highly valuable.

Similarly, if you are a researcher who consistently prioritizes publishing your work over patenting it, or if you have a practice of working closely with the TTO before submitting your research to a journal, I would greatly appreciate your perspective.

Your contributions to this topic will not only be beneficial but will also be acknowledged in my upcoming book.

I invite you to join me for a virtual coffee to discuss further. Please feel free to book a slot in my agenda:

👉https://lnkd.in/giKpAzFa

"Science-to-Paper or Science-to-Patent, that is the question"

Ari Massoudi | LinkedIn

Hosted on Acast. See acast.com/privacy for more information.

The Magic of Illustrations: Make Your Scientific Communication Memorable

In the fascinating world of scientific exploration, where intricate concepts and pioneering research reign supreme, the significance of visual communication is paramount. Dr. Daria Chrobok, a plant biologist and the visionary behind DC SciArt, is a trailblazer in this domain, seamlessly merging scientific acumen with captivating artistic flair. Her inspiring journey, beautifully captured in a recent interview, highlights the transformative potential of uniting art and science, particularly through the medium of scientific illustrations.

The Birth of a Creative Pioneer

From her formative years, Daria was nurtured in an environment where art and science coalesced effortlessly. Born to a father who was a versatile artist and a mother who encouraged her creative leanings, Daria's childhood was a vibrant tapestry of nature's colors and artistic brushstrokes. This unique fusion of influences shaped her academic trajectory, leading her to pursue both biology and art during her high school education in Germany—an uncommon pairing that paved the way for her future exploits.

Uniting Two Realms

Daria's scholarly voyage in plant biology was characterized by a deep-seated reverence for the natural world, a sentiment that was intricately entwined with her artistic instincts. However, it was during her doctoral studies that she confronted the constraints and often inflexible frameworks of academic research. This revelation triggered a pivotal transition, guiding her towards a path where she could harmoniously merge her twin passions with greater freedom and impact.

The Inception of DC SciArt

DC SciArt was born from this vision. It's more than just a business; it's a channel for amplifying scientific communication through art. Daria's creations fill a vital void in the scientific community—transforming intricate, complex scientific data into approachable, captivating visual stories. Her illustrations don't merely represent scientific principles; they infuse them with life, making them relatable and comprehensible for a wide array of audiences.

A Champion for Researchers and Communicators

For academic researchers, Daria's proficiency in scientific illustration is a ray of light. By translating sophisticated research findings into engaging visuals, she aids researchers in communicating their work more effectively, not only within the academic sphere but also to the general public. This is indispensable in a time where science communication can bridge the chasm between research and societal influence.

Scientific journal publishers also reap considerable benefits from Daria's work. In a field where the aesthetic appeal of articles can significantly affect reader engagement and understanding, her illustrations offer a visual and practical enhancement to publications. They not only improve the readability of complex studies but also boost their citation potential, as visually appealing articles are more likely to be circulated and discussed.

Furthermore, marketing and communication managers in science-based enterprises find a valuable partner in Daria. Her illustrations function as potent marketing tools that can simplify complex product information, making it easier for potential clients to comprehend and value the worth of scientific products or innovations.

https://www.linkedin.com/in/dariachrobok/

https://www.dariasciart.com/

https://www.instagram.com/dc_sciart/

Hosted on Acast. See acast.com/privacy for more information.

From Tech Wunderkind to Anti-Aging Warrior: Gabriel Cian's Odyssey

Is aging a disease we can cure? Tech entrepreneur Gabriel Cian is betting on it. Dive into his incredible journey from coding prodigy to longevity pioneer, and discover the audacious mission that could change humanity's future.

A Life on Fast Forward: Born into a family where academic excellence was king, Gabriel's childhood was a launchpad for greatness. Bucharest's whiz kid turned Parisian polymath, he defied expectations by ditching a coveted engineering path for the uncharted waters of tech startups.

Building Empires and Burning Doubts: Join our podcast as Gabriel unveils his early ventures, defying skepticism and proving that even teenagers can change the world with a good idea and unwavering determination.

The Ultimate Disruption: Hacking Mortality: What drives a successful entrepreneur to tackle aging itself? This episode explores Gabriel's encounter with transhumanism and his audacious quest to extend human healthspan.

A Roadmap to a Longer Life: Unravel Gabriel's strategic approach to navigating the cutting-edge world of longevity research. Discover his partnership with another brilliant mind, Max Kamrani, and their foundation, "2060," aiming to make aging obsolete.

Why You Should Listen:

This podcast isn't just an interview, it's an inspiration rocket. It's a story of defying odds, chasing dreams, and leaving an indelible mark on humanity. Whether you're a tech enthusiast, a longevity skeptic, or simply someone who wants to live life to the fullest, this episode is a must-listen.

Join us as we unlock the secrets of Gabriel Cian, the visionary redefining what it means to grow old. Tune in, get inspired, and be a part of the conversation that could change the future of aging.

https://2060.life/

https://www.linkedin.com/in/gabriel-cian-807b39156/

Hosted on Acast. See acast.com/privacy for more information.

ITW Dr Amir Feizpour - Founder-CEO at Aggregate Intellect

AI and the Future of Law: Boon or Bane for Lawyers?

In the rapidly evolving tech landscape, AI is transforming the legal profession. In a live podcast, I discussed this with Dr. Amir Feizpour, CEO of Aggregate Intellect, and Dr. Benjamin Delsol, quantum physicist and patent attorney. Dr. Feizpour shared insights on how AI, like large language models, is revolutionizing legal practice by expediting research, drafting documents, and enhancing client interaction.

Imagine AI sifting through thousands of patent documents in a complex dispute, or drafting a divorce agreement in a family law case. AI can alleviate research burden, reduce human error, and enable lawyers to focus on nuanced aspects of legal work. Dr. Feizpour shared his experience of using AI to draft contracts, significantly reducing time and cost.

However, AI integration in law presents challenges like ethical implications, potential errors, and impact on traditional practice. Our conversation offers a glimpse into the future of law, where AI and human expertise unite for a more efficient, accurate, and accessible legal system.

To understand AI's transformative role in law, watch or listen to our full interview. Discover how AI is not just a tool for tech enthusiasts, but a powerhouse for the legal profession. Join us in exploring AI's positive impacts on law and how it can elevate your practice. This post only skims the surface; for a comprehensive exploration, watch or listen to the full interview. The future of law is here, powered by AI. Don't miss this chance to stay ahead.

Amir's contact information:

- https://calendly.com/amirfzpr

- https://www.linkedin.com/in/amirfzpr/

- https://aisc.substack.com/

- https://www.youtube.com/@ai-science

Hosted on Acast. See acast.com/privacy for more information.

ITW Dr Thomas Trautmann - Fondateur Happy Brains

Entrepreneurs mariés, découvrez comment les neurosciences peuvent vous aider à obtenir plus

Dans ce nouvel épisode, j’ai le plaisir d’avoir comme invité le Dr. Thomas Trautmann, fondateur de Happy Brains.

Un parcours scientifique et professionnel riche

Thomas Trautmann est un scientifique et un entrepreneur expérimenté. Après des études d’ingénieur en informatique, il obtient un doctorat en intelligence artificielle (pionnier des réseaux de neurones) de l'Université de Technologie de Compiègne. Tout juste son doctorat en poche, il quitte le monde Académique pour le secteur privé technologique où il développe son expertise en marketing et la vente.

En 2013, il rejoint SalesBrain en tant que Business Partner, une entreprise américaine pionnière du neuromarketing. Après plusieurs années à échanger avec les chef d’entreprise, il réalise qu’il peut aller plus loin que le neuromarketing (qui s’addresse aux clients des entreprises) et que pour cela, il doit augmenter le «zoom» de son expertise. Dans ce but, en 2016, il fonde Happy Brains, une entreprise de coaching et de formation qui aide les entrepreneurs et tout particulièrement les entrepreneurs mariés à utiliser les neurosciences pour améliorer leur réussite.

Les neurosciences peuvent aider les entrepreneurs de différentes manières :

Améliorer la prise de décision

Les neurosciences nous aident à comprendre comment notre cerveau prend des décisions. En comprenant ces mécanismes, nous pouvons apprendre à prendre des décisions plus éclairées et plus efficaces.

Augmenter la persuasion

Les neurosciences nous aident à comprendre comment notre cerveau est influencé par les autres. En comprenant ces mécanismes, nous pouvons apprendre à persuader les autres de manière plus efficace et éthique.

Améliorer les relations

Les neurosciences nous aident à comprendre comment notre cerveau fonctionne dans les relations. En comprenant ces mécanismes, nous pouvons apprendre à améliorer nos relations personnelles et professionnelles.

https://www.linkedin.com/in/thomastrautmann/

https://www.happy-brains.com/

Hosted on Acast. See acast.com/privacy for more information.